A detailed history of Estabrook Capital Management transactions in Zoetis Inc. stock. As of the latest transaction made, Estabrook Capital Management holds 67 shares of ZTS stock, worth $12,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67
Previous 52 28.85%
Holding current value
$12,148
Previous $8.8 Million 32.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $2,183 - $2,682
15 Added 28.85%
67 $11.6 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $828 - $999
5 Added 10.64%
52 $8.8 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $9,103 - $11,610
47 New
47 $11,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Estabrook Capital Management Portfolio

Follow Estabrook Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Estabrook Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Estabrook Capital Management with notifications on news.